PATTERSON RESEARCH GROUP
Our research group aims to optimise functional outcomes and quality of life in head and neck cancer, with strong collaborations regionally, nationally and internationally. Our programme covers a range of topics and issues, from diagnosis to end of life, from the perspective of patients and carers.
This work spans qualitative, quantitative and mixed methods, using designs including systematic reviews, feasibility and pilot studies to randomised control trials. We are closely aligned with Liverpool Head and Neck Centre’s Patient Forum, Patient & Public Research Groups | Liverpool Head & Neck Centre who provide a strong foundation and partnership, informing research development to dissemination. Our group has representation across healthcare disciplines (Head and Neck Surgeons, Oncologists, Nurses, Allied Healthcare Professionals), academics (Exercise Physiologists, Behavioural Scientists), methodologists, PhD candidates and early-career researchers.
-
Prehabilitation and enhanced recovery
Prehabilitation can improve quality of life and reduce treatment complications in cancer care. Integrating prehabilitation into routine HNC care poses huge challenges, due to the nature of symptoms and side-effects, a limited time-frame before the onset of treatment, and a complex care pathway. Our focus is on developing and evaluating prehabilitation and enhanced recovery interventions, to improve patients’ physical and psychological well-being. Hear more about our work here.
Patient reported measures
Information on the impact of head and neck cancer and its treatment taken from patients’ and carers’ perspectives are crucial for accurate information provision, decision-making, directing consultations, robust research end-points and informing guidelines. Our work includes developing patient-reported measures and symptom indices, re-purposing and testing existing measures for different populations and integrating them into clinical care for patient benefit. (Links to projects). We are optimizing and evaluating mechanisms to enhance completion of measures, including digital platforms.
Support and rehabilitation
Head and neck cancer and its treatment can have a huge impact on patients’ and carers’ daily lives, affecting functions such as breathing, communication, swallowing and activity, with multiple symptoms including pain, fatigue and altered appearance. Physical, emotional, social, and financial concerns are common, impacting on quality of life, and influencing treatment
-
tba
-
tba
-
tba
Our Research Group
-
-
Dr Michelle Lawton
HEE/NIHR Advanced Clinical & Practitioner Academic Fellow
Michelle is a Clinical Academic Speech and Language Therapist, specialising in dysphagia (swallowing difficulties), working across the University of Liverpool and Mid Cheshire NHS Trust. She is currently undertaking an NIHR Advanced Fellowship, developing and evaluating the feasibility of a novel intervention to improve swallow function for people following head and neck cancer, in addition to working clinically as an Advanced Clinical Specialist in head and neck oncology. She is passionate about developing innovative technologies through research to improve patient outcomes.
Michelle received her undergraduate degree in Speech Pathology and Therapy from Manchester Metropolitan University (BSc (Hons): first) in 2003. She went on to complete a PhD at the University of Manchester, winning a Stroke Association postgraduate Fellowship in 2013. As part of her PhD, Michelle developed a psychometric scale to measure the impact of developing a positive therapeutic alliance in aphasia rehabilitation, which is now being translated internationally. Following her PhD, she secured an NIHR postdoctoral bridging Fellowship in 2021 and Advanced Fellowship in 2023.
Michelle has over 20 years of clinical experience in assessment and management of dysphagia and communication impairment arising from multiple aetiologies. Her clinical and research interests include: prehabilitation, outcome measurement, instrumental assessment, respiratory disorders, psychosocial adjustment and novel swallow interventions. She has presented nationally and internationally and taught at undergraduate and postgraduate level. She is mentor for research-active healthcare professionals and a supervisor for pre-doctoral and doctoral students.
Michelle leads the ‘Improving Outcomes in Head and Neck Cancer’ research seminars at the Liverpool Head and Neck Centre. She is a mentor and research champion for The Royal College of Speech and Language Therapists and a steering group member of the Council of Allied Health Professions Research (CAHPR).
Academic qualifications
2013 –2018 PhD in Psychology
(part-time 0.6) University of Manchester
2000 – 2003 BSc (Hons) in Speech Pathology and Therapy - first class
Manchester Metropolitan University
1994-1997 BA (Hons) Degree in Social Sciences
-
Sarah Stephens
Doctoral Candidate
Find out more
Sarah’s research aims to explore how transoral surgery affects swallowing and communication in the first six weeks following surgery for cancer of the oropharynx (part of the throat directly behind the mouth that helps you speak and swallow).
Sarah’s research will provide:
In depth analysis of early post operative changes to function (speech and swallowing) which will allow clinicians to delineate which patients benefit functionally from transoral surgery thereby facilitating the complex treatment decision-making process
Evidence on the impact of surgical technique (transoral laser microsurgery vs transoral robotic surgery) which will guide policy and clinical decision making
Greater understanding of functional changes which will improve pre-treatment education, thus reducing anxiety and engagement (patients and carers) in the post-operative period.
Qualitative data to enhance the understanding of oropharyngeal dysfunction, highlighting the timing and nature of functional problems, alongside patient and carer priorities. This will optimise care pathways and efficient clinical management. It will also enhance understanding of patient experience of functional assessments and data collection processes.
a set of core outcome measures, which has been identified by an international panel of experts (clinicians and patients), aiming to reduce heterogeneity in future research data, allowing for comparisons amongst observational studies, strengthening the evidence available to clinicians.
Supervisors: Professor Jo Patterson,
-
Laura-Jayne Watson
NIHR Doctoral Clinical & Practitioner Academic Fellow
Find out more
Laura-Jaynes doctoral thesis aims to better understand what care people with a laryngectomy and their families need at home.
Research Question:
What are the healthcare needs of laryngectomy patients and their families following discharge after surgery and how can these be incorporated into a prototype education and training package for use by community healthcare professionals?
Research Objectives:
1. To identify and critically review available laryngectomy education and training packages (ETP)
2. To explore patient and family members experiences and needs from community healthcare services following laryngectomy
3. To co-design a prototype laryngectomy ETP for community healthcare professionals
Methods:
There will be three work-streams in this research:
· Work-stream 1: Environmental scan of available laryngectomy ETP’s
· Work-stream 2: Semi-structured qualitative interviews with laryngectomy patients and family members
· Work-stream 3: Co-design workshops with patients, families and healthcare professionals to design a prototype ETP
Two simultaneous groups will run alongside the research: patient-advisory group and healthcare professional stakeholder advisory group. Both groups will review findings from the environmental scan and semi-structured interviews to shape the co-design phase and ensure the research stays grounded in patient experience and service needs.
Supervisors: Professor Jo Patterson,
-
Shamah Alnahham
Doctoral Candidate
Find out more
Shamah’s research aims to evaluate the diagnostic accuracy of screening tests for detecting aspiration in patients with head and neck cancers. Throughout thesis, Shamah presents three different studies. An initial systematic review will be conducted to assess the diagnostic accuracy of swallowing screening tools for detecting aspiration among head and neck cancer patients. Using existing data, the second study will evaluate the diagnostic accuracy of the 100mL Water Swallow Test for detecting aspiration will be compared with videofluoroscopic swallowing evaluations for patients with HPV+ Head & Neck Cancer. The final study will use a modified water swallow test to screen people treated for head and neck cancer for aspiration.
Supervisors: Joanne Patterson, Michelle Lawton, Jenan Altamimi, Andrew Schache
-
Linda Cantwell
Doctoral Candidate
tba
Former Members
-
Emily Pearson
Doctoral Candidate
Understanding emotional challenges after treatment for head and neck cancer.
A head and neck cancer diagnosis can have a threat to life and treatments can be invasive and life changing. Treatment regimens can impair physical and psychological well-being caused by facial disfigurement and / or disability, such as difficulties speaking, breathing, or swallowing. Therefore, difficulties with emotional distress such as depression, anxiety and cancer-related post-traumatic stress symptoms can occur. Studies have suggested that people with HNC have increased risk of emotional distress and suicidal tendencies in comparison with other tumour types as well as being four times higher than the general population.
Research exploring psychological mechanisms that underpin the development of emotional difficulties and keep them going is limited within HNC. This cross-sectional study will investigate the role of metacognitive beliefs and self-compassion in the development and maintenance of anxiety, depression, and cancer-related post-traumatic stress. The study will collect questionnaire measures at one time point and will use quantitative methods to analyse the data. Participants will be able to complete the measures using an online link or using paper and pen.
The study is being conducted as partial completion of the Doctorate in Clinical Psychology at the University of Liverpool and has been designed in conjunction with the Aintree Patient and Participation Involvement group at the HNC unit at Aintree Hospital. The findings will be published in a peer reviewed journal and will help us understand psychological interventions for people with HNC and how we can help minimise distress following treatments
Collaborators
-
Professor Heather Starmer, Stanford Medicine
Clinical Professor and Director of the Head and Neck Cancer Speech and Swallowing Rehabilitation Center
Find out more
Heather Starmer is a Clinical Professor and Director of the Head and Neck Cancer Speech and Swallowing Rehabilitation Center. She is a Board Certified Specialist in Swallowing and Swallowing Disorders. in 2023 she was awarded the prestigious Fellow designation by the American Speech Language and Hearing Association (ASHA).
Prior to joining the faculty at Stanford University, Professor Starmer served as the lead of the head and neck cancer rehabilitation program at Johns Hopkins University.
She has pursued doctoral studies at the University of Liverpool with completion of her PhD in Applied Health Research in 2024. Her doctoral dissertation focused on the assessment of head and neck lymphedema with a particular emphasis on the patient experience and quality of life.
Professor Starmer specialises in the rehabilitation of speech, voice, and swallowing in patients with head and neck cancer. She has particular interest in prevention of communication and swallowing disorders associated with radiation and chemotherapy. She has a strong interest in head and neck cancer survivorship and helping patients to accomplish their personal goals and to optimize their quality of life long term.
Professor Starmer's academic goals include improving communication and swallowing outcomes following a diagnosis of head and neck cancer through clinical research. She was a key member of a collaborative research group at Johns Hopkins resulting in multiple publications and presentations on strategies to minimize speech and swallowing difficulties. Recent advances in pain management during radiation therapy developed by this research collaborative have already shown great promise in protecting patients from potential swallowing difficulties during and after their cancer treatment. She works closely with colleagues in surgery, radiation oncology, and medical oncology to tackle the often difficult problems encountered by patients with head and neck cancer. She has particular interest in investigating the role of innovative surgical techniques such as Transoral Robotic Surgery (TORS) in minimizing long term functional deficits. She regularly collaborates with colleagues around the globe to develop innovative solutions to challenges encountered by head and neck care teams and the patients they serve. -
Professor Adrian Midgely
Professor of Clinical Exercise Physiology, Edge Hill University
Find out more
Biography
Adrian has been a member of the sport and exercise science programme team within the Department of Sport and Physical Activity since October 2012. He was previously a lecturer at the University of Hull at which he completed his PhD in exercise physiology. He currently leads BSc Sport and Exercise Science modules in exercise and health and in clinical exercise physiology. In addition to his academic qualifications in sport and exercise science, Adrian holds many vocational qualifications in health and fitness, including specialist qualifications in cancer, cardiovascular disease, obesity and diabetes, exercise referral, older adults, pre- and postnatal exercise, corrective exercise, and management of low back pain He is the Designated Individual for human tissue compliance within the University, and sits on the central university ethics committee.
Research Interests
Adrian’s is probably best known for his research into the measurement and development of cardiorespiratory fitness. He also has a strong interest in factors that explain exercise tolerance during maximal exercise. His current research focuses on exercise testing and prescription in clinical populations, such as those with head and neck cancer, cardiac disease, and pulmonary disease.
-
Dr Catriona Mayland
Senior Clinical Lecturer, University of Sheffield
Find out more
Catriona joined the University of Sheffield in 2018 after obtaining a Yorkshire Cancer Research (YCR) ‘CONNECTS’ Senior Clinical Research Fellowship. She is also an Honorary Consultant in Palliative Medicine at Sheffield Teaching Hospitals NHS Foundation Trust.
Catriona was awarded my Doctor of Medicine (MD) degree from the University of Liverpool in 2010. Her MD evaluated quality of care for dying patients and their families (last days of life) as perceived by bereaved relatives. From this work, she developed and validated the international ‘Care Of the Dying Evaluation’ (CODETM) tool.
Catriona’s belief that palliative care should help address injustices and inequities drives her research interests. These include complex cancer groups e.g., head and neck cancer, mesothelioma, and improving access and integration of palliative care, including bereavement support, through inclusive methodology.
-
Professor Chris Ward
Professor of Respiratory Physiology, Newcastle University
Find out more
Chris has made significant contributions to respiratory physiology over 35 years, publishing over 300 papers. His work focuses on human lung injury, remodeling, comorbidity, and treatment effects. Funded by organizations like NHMRC, MRC, and Wellcome, his research has practical implications. The Ward lab’s pioneering work on neutrophilic airway pathophysiology and differentiated airway epithelium has impacted lung research including COVID discovery research.
Supervision and Collaboration: Chris has supervised 15 PhD students in the UK, fostering effective working relationships. His postdocs have transitioned to clinician scientist roles, and overseas students have become PIs and associate professors.
Impact and Engagement: Chris actively engages with patients, initiating a fibrotic lung disease user group. His research has influenced clinical practice, including lung transplantation and CF clinics. His overseas students have applied their training in COPD prognostication and infectious diseases. His commitment to broader societal benefit extends to teaching and linking NHS and University colleagues.
-
Gemma Cherry
TBA
-
Linda Sharp
TBA
-
Professor Mike Drinnan
Professor of Digital Healthcare Interventions, Teeside University
Find out more
Mike joined Teesside University in November 2023 after a long career in the North-East NHS, leading groups that specialise in physiological measurement and in medical device development, regulation and assessment.
Mike’s academic activities have been linked with his NHS role in developing novel med-tech, and also with the training of healthcare professionals, notably through the UK's Scientist Training Programme (STP).
-
David Hamilton
consultant ENT, head, neck and thyroid surgeon
Find out more
David (known as “Winnie) is a consultant ENT, head, neck and thyroid surgeon at the Freeman Hospital in Newcastle. His clinical work centres on developing safe processes of care, reducing inequality and developing the roles of Allied Healthcare Professionals and trainee surgeons. He is currently the Health & Care Research Director for the North East and North Cumbria RRDN.
His research interests are broad but his main focus is on optimising patient centred outcomes in head and neck cancer. He has expertise in shared decision making and informed consent and co-led the development of the Royal College of Surgeons of Edinburgh “Informed Consent: Sharing the Decision” ICONS course. He is also the chief investigator for the Laryngeal Cancer Cohort (LARCH) which runs across the Northern Head and Neck Cancer Alliance
Patient and Public Involvement
-
Val Byrant
Lead of HNC patients called CHANGE who support studies, promoting the patient voice.
Find out more
Val spent 37 years in education before retiring in 2010 after undergoing Chemo/radiotherapy for Head and Neck Cancer ( HNC). The effects of this mean she is reliant on PEG feeding for most of her nutrition.
After taking part in a study into Altered Eating Val became involved in research. She is currently a co applicant on 5 studies and has co authored several papers.
In 2017 she was presented with a Giving Voice award on behalf of the RCSLT.
In 2022 she became the first Patient President at the Swallows International Conference.
In May 2023 she was awarded Honorary Life Membership of BAHNO.
She leads a small group of HNC patients called CHANGE who support studies, promoting the patient voice.
-
Vince Killen
Vice-Chair and Secretary of the HaNC PPI Research Forum
Vince is a head and neck cancer patient, who was initially diagnosed in 2005 and subsequently with osteoradionecrosis in 2016.
He is Vice-Chair and Secretary of the HaNC PPI Research Forum Patient & Public Research Groups | Liverpool Head & Neck Centre a group of Cheshire and Merseyside patients and carers who support research into head and neck cancer, primarily undertaken by the Liverpool Head and Neck Centre.
Vince is retired and was formerly a Director of the Shop Direct/Littlewoods Group and a Trustee of the Liverpool Everyman/Playhouse Theatres.
RESEARCH
-
tba
-
tba
-
The Patient Concerns Inventory (PCI-HN) is a condition specific prompt list. The concept stems from the literature on the value of question prompt lists in oncology, however as an item the approach has a simplicity which enables its integration into routine care. The PCI-HN was developed as a tool to help overcome some of the difficulties inherent in Health-Related-Quality-of-Life (HRQOL) questionnaires, notably the limited number of issues, the wording, the reliance on Likert scoring as an outcome and the patient questionnaire burden.
The PCI-HN was developed through patient focus groups and first published in 2009 [1]. It is a tool for use in post treatment consultations to help patients raise issue that otherwise, though important, can be missed. It compromises of a list of 56 items and covers physical, treatment, social care, psychological and spiritual aspects. In addition, the PCI-HN lists 18 allied professionals and asks patients to select any that they would like to talk with in clinic or by referral. A systematic review and content comparison of unmet needs self-report measures used in patients with head and neck cancer favoured the PCI compared to 13 other tools [2]. There is also a PCI-HN with specific items appropriate for use at the time of diagnosis of head and neck cancer [3]. The PCI is a free to use resource.
There have been numerous papers on the PCI and these support the premise that:
· It is feasible in routine patient care
· It is appreciated by patients
· It is a tool that helps the ‘hard to reach’ such as elderly and those from low socioeconomic backgrounds.
· It facilitates the ‘conversation’ around potential unmet needs
· Its frequent use provides multiple opportunities for intervention
· It had stratified and make more appropriate the referrals to disciplines (targeted signposting)
· A realisation of the common issues serves as drivers for change reflecting patient experience
· A randomised trial (RCT) provides evidence of benefit as a low-cost intervention which improves patients quality of life
· The PCI approach has been developed in other cancers and long-term conditions such as neuro-oncology, burns, rheumatology, stroke
1.Rogers SN, El-Sheikha J, Lowe D. The development of a PatientsConcerns Inventory (PCI) to help reveal patients concerns in thehead and neck clinic. Oral Oncol 2009. Jul;45(7):555-61. doi:10.1016/j.
2.Shunmugasundaram C, Rutherford C, Butow PN, Sundaresan P, DhillonHM. Content comparison of unmet needs self-report measures used inpatients with head and neck cancer: A systematic review. Psychooncology2019. Dec;28(12):2295-2306.
3.Byrne MJ, Rogers SN (2017) Service evaluation of patients’ views on the Patients’ Concerns Inventory (at diagnosis). Br J Oral Maxillofac Surg 55(7):714–716.
You can access the PCI-HNC here:
-
This feasibility study is funded by the NIHR Research for Patient Benefit and aims to understand and evaluate head and neck cancer (HaNC) patients’ engagement in physical exercise. The vast majority of HaNC patients have low levels of physical activity, associated with substantial treatment side-effects. The project will develop a collaborative, flexible, patient-centred personalised programme, with tools to support HaNC-specific barriers to exercise, and test whether this is feasible and acceptable. 35 HaNC patients will be recruited across Liverpool and Sunderland. Physiotherapists will work with local Cancer Exercise Specialists to devise a personalised exercise programme, using support tools to overcome HaNC-specific barriers, with weekly virtual support. We will assess; rates of uptake, retention and exercise completion; patient reported symptoms and QOL; physical fitness. We will interview patients and healthcare professionals. Our study will determine whether further research into personalised exercise programmes is feasible and worthwhile.
Our team includes
Professor Jo Patterson, Speech & Language Therapist, University of Liverpool
Val Bryant PPI representative
Professor Adrian Midgley, Clinical Exercise Physiologist and certified Cancer Exercise Specialist
Dr Andy Levy, Reader and Chartered Exercise Psychologist, Edge Hill University
Professor Simon Rogers, Consultant HNC Surgeon, Edge Hill University
Mr Mike Nugent, Consultant HNC Surgeon, South Tyneside and Sunderland NHS Foundation Trust
Mr Andrew Schache, Consultant HNC Surgeon and Reader at University of Liverpool
Ruth Price, Specialist HNC Physiotherapist, University of Liverpool Hospitals Foundation Trust
Dr Brooker, Academic Clinical Oncologist, Clatterbridge Cancer Centre, Liverpool
Dr Steven Lane Medical Statistician, University of Liverpool
Professor Bridget Young, Qualitative Methodologist, University of Liverpool
Collaborator: Dr Gillian Prue Queens University Belfast, Chair of the NCRI Acute Care and Toxicities Workstream and member of the Living With and Beyond Cancer Group
-
The study aims to improve the experiences of patients with incurable head and neck cancer (IHNC) by finding out the most pressing issues for them and developing solutions to improve these.
How will we do this?
1. A series of up to three interviews, over an 8-month period, with incurable head and neck cancer patients and their families, along with group discussions with healthcare workers involved in head and neck cancer care. These will explore how patients’ needs and use of healthcare change over time.
2. Using interview and group discussion findings, we will hold a series of workshops with patients, families, clinical service leaders, and healthcare workers. We will identify priorities and develop ways to improve care experiences.
The study was awarded funding from the NIHR Research for Patient Benefit programme.
To find out more, please contact:
TBC